479 related articles for article (PubMed ID: 2191847)
1. Antineoplastic drugs in 1990. A review (Part II).
Black DJ; Livingston RB
Drugs; 1990 May; 39(5):652-73. PubMed ID: 2191847
[No Abstract] [Full Text] [Related]
2. Cancer chemotherapeutic agents.
Oswalt CE; Cruz AB
Tex Med; 1977 May; 73(5):57-67. PubMed ID: 860280
[No Abstract] [Full Text] [Related]
3. The clinical pharmacology and use of antineoplastic drugs.
Greco FA; Hande KR
J Tenn Med Assoc; 1979 Jan; 72(1):23-33. PubMed ID: 423575
[No Abstract] [Full Text] [Related]
4. [The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors].
Schönfelder M
Zentralbl Chir; 1974 Sep; 99(38):1198-208. PubMed ID: 4454780
[No Abstract] [Full Text] [Related]
5. Antineoplastic chemotherapy.
Mutz ID; Vietti TJ
South Med J; 1977 Jul; 70(7):847-54. PubMed ID: 327567
[No Abstract] [Full Text] [Related]
6. Anticancer chemotherapy.
Davey P; Tudhope GR
Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699
[No Abstract] [Full Text] [Related]
7. Chemotherapy in gynecological malignancies--and its nursing aspects.
Wahl TP; Blythe JG
JOGN Nurs; 1976; 5(5):9-14. PubMed ID: 1049284
[No Abstract] [Full Text] [Related]
8. Chemotherapy of solid tumors.
Alberto P
Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
[No Abstract] [Full Text] [Related]
9. Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids: clinical developments.
Brenner DE
Curr Opin Oncol; 1990 Dec; 2(6):1115-8. PubMed ID: 2099842
[No Abstract] [Full Text] [Related]
10. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in the management of malignant urogenital neoplasms.
Schnipper LE
Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317
[No Abstract] [Full Text] [Related]
12. Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids.
Hande KR
Curr Opin Oncol; 1992 Dec; 4(6):1080-8. PubMed ID: 1457522
[TBL] [Abstract][Full Text] [Related]
13. Vinca alkaloids vs. taxanes as therapy in lymphoid malignancies: do our experimental models obscure our understanding of how these drugs really work?
Lerner A; Andrea N
Cancer Invest; 2005; 23(1):100-2. PubMed ID: 15779874
[No Abstract] [Full Text] [Related]
14. Cytotoxic agents for use in dermatology. I.
McDonald CJ
J Am Acad Dermatol; 1985 May; 12(5 Pt 1):753-75. PubMed ID: 3891799
[TBL] [Abstract][Full Text] [Related]
15. Interactions between calcium channel blockers and non-cardiovascular drugs: interactions with anticancer drugs.
Baeyens JM
Pharmacol Toxicol; 1988 Jul; 63(1):1-7. PubMed ID: 3041398
[No Abstract] [Full Text] [Related]
16. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
Zamora JM; Pearce HL; Beck WT
Mol Pharmacol; 1988 Apr; 33(4):454-62. PubMed ID: 3162758
[TBL] [Abstract][Full Text] [Related]
17. [Effect and role of vinca-alkaloids in the treatment of metastatic breast cancers].
Herrera A; Delgado FM; Besenval M; Merle S; Badri N; Marty M; Krikorian A
Pathol Biol (Paris); 1990 Oct; 38(8):860-1. PubMed ID: 2274391
[No Abstract] [Full Text] [Related]
18. Current developments in antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids.
Rowinsky EK
Curr Opin Oncol; 1991 Dec; 3(6):1060-9. PubMed ID: 1843108
[TBL] [Abstract][Full Text] [Related]
19. Cancer chemotherapy: What drugs are available.
Carter SK; Kershner LM
Med Times; 1976 Feb; 104(2):154-62. PubMed ID: 1246181
[No Abstract] [Full Text] [Related]
20. Management of Kaposi's sarcoma. Chemotherapy I.
Vogel CL
Antibiot Chemother (1971); 1981; 29():82-7. PubMed ID: 7027912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
